Finance

Lists
Why is EVT up २.०५%?
Dive Deeper
EVT:FRA
Evotec SE
€ २.८९
+२.०५%
(+०.०५८) 1D
अक्टोबर ८, २२:००:०० GMT+२  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for EVT...
Open
€ २.८९
High
€ २.८९
Low
€ २.८९
Mkt. cap
४८.९८ करोड
Avg. vol.
४.६५ हजार
Volume
०.००
52-wk high
€ ७.४९
52-wk low
€ २.७३
EPS
-€ १.११
Shares outstanding
१४.८७ करोड
No. of employees
४ हजार
Open
€ २.८९
High
€ २.८९
Low
€ २.८९
Mkt. cap
४८.९८ करोड
Avg. vol.
४.६५ हजार
Volume
०.००
52-wk high
€ ७.४९
52-wk low
€ २.७३
EPS
-€ १.११
Shares outstanding
१४.८७ करोड
No. of employees
४ हजार
News stories
From web sources and news partners
AD HOC NEWS
AD HOC NEWS
·
४ घण्टा पहिले
Evotec stock loses 3.44 percent after-hours to EUR 2.81
AD HOC NEWS
AD HOC NEWS
·
९ घण्टा पहिले
Berenberg keeps Hold for Evotec stock at EUR 3.60 target
AD HOC NEWS
AD HOC NEWS
·
१ दिन पहिले
Evotec loses research chief. Evotec stock falls 2.03 percent
Profile
Evotec SE is a publicly listed drug discovery and development company headquartered in Hamburg, Germany. The company operates globally, largely through external alliances with pharmaceutical and biotechnology companies, academic institutions, patient advocacy groups, and venture capitalists. As of 31 December 2021 Evotec had a market capitalization of €7.5 billion and a pipeline of more than 130 partnered programs in discovery, pre-clinical development and clinical development. The company's 4,200+ employees work across a number of therapeutic areas including CNS/neurology, metabolic diseases, Cancer, and inflammatory and infectious diseases. It has long-term discovery alliances with Bristol Myers Squibb, Bayer, Sanofi, Boehringer Ingelheim, the CHDI Foundation, Lilly, Takeda, Sernova, and more. On 28 October 2009 the company was listed on the TecDAX index, which tracks the performance of the 30 largest German companies from the technology sector. On 24 September 2018 Evotec joined the MDAX index, following a rule change that enabled dual listing. The MDAX tracks 60 Prime Standard shares from sectors excluding technology. Wikipedia
About Evotec SE
CEO-
Employees४.४६ हजार
Founded१९९३
Headquarters-
Sector-
Websiteevotec.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
१६.३९ करोड
२५.३३ करोड
१५.६६ करोड
१४.३५ करोड
Cost of goods sold
१६.३९ करोड
१७.४८ करोड
१५.८२ करोड
१४.५१ करोड
Cost of revenue
१६.३९ करोड
१७.४८ करोड
१५.८२ करोड
१४.५१ करोड
Research and development expenses
८७.१३ लाख
९८.२८ लाख
१.०१ करोड
१.०३ करोड
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
४.२३ करोड
४.४४ करोड
४.३८ करोड
३.९३ करोड
Operating expense
४.३५ करोड
५.५२ करोड
४.४९ करोड
८.७७ करोड
Total operating expenses
२०.७५ करोड
२३.०१ करोड
२०.३१ करोड
२३.२८ करोड
Operating income
-४.३६ करोड
२.३२ करोड
-४.६४ करोड
-८.९३ करोड
Other non operating income
११.९२ लाख
-३.४० करोड
१८.९३ लाख
-८.३९ लाख
EBT including unusual items
-४.३० करोड
२.९५ करोड
-१२.२२ करोड
-४.८१ करोड
EBT excluding unusual items
-४.३४ करोड
१.८३ करोड
-४.७४ करोड
-९.४० करोड
Income tax expense
१.२७ लाख
१.४८ करोड
-२.४४ लाख
-१४.७१ लाख
Effective tax rate
-०.३०%
५०.३७%
०.२०%
३.०६%
Other operating expenses
-७४.९७ लाख
१०.७१ लाख
-९०.१५ लाख
३.८२ करोड
Net income
-४.३१ करोड
१.४६ करोड
-१२.१९ करोड
-४.६६ करोड
Net profit margin
-२६.२९%
५.७७%
-७७.८४%
-३२.५१%
Earnings per share
-०.२४
-
-
-
Interest and investment income
८.४१ लाख
१.१८ करोड
-
-
Interest expense
-२२.८३ लाख
-
-२५.८३ लाख
-२९.७४ लाख
Net interest expenses
-१४.४२ लाख
१.१८ करोड
-२५.८३ लाख
-२९.७४ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-१.८३ करोड
४.१९ करोड
-२.२६ करोड
-६.४९ करोड
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google एपहरू